Krintafel 150 mg/1
tafenoquine succinate · TABLET, FILM COATED · GlaxoSmithKline LLC
No Recall History
Plain English
Krintafel is a tablet, film coated containing tafenoquine succinate at 150 mg/1, taken oral. Manufactured by GlaxoSmithKline LLC.
Key Facts
- Brand Name
- Krintafel
- Generic Name
- tafenoquine succinate
- NDC Code (Product)
0173-0889- Manufacturer
- GlaxoSmithKline LLC
- Strength
- 150 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA210795
- Marketing Start
- 01/22/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Krintafel used for?
Krintafel contains tafenoquine succinate. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Krintafel a controlled substance?
Krintafel is not classified as a controlled substance by the DEA.
What is the generic name for Krintafel?
The generic name for Krintafel is tafenoquine succinate. There are no other listed brand versions of tafenoquine succinate.
What is the NDC code for Krintafel 150 mg/1?
The NDC (National Drug Code) for Krintafel 150 mg/1 is 0173-0889, listed by GlaxoSmithKline LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)